Novartis Halts CAR-T Trials After Fatalities
Novartis paused eight clinical trials of an experimental therapy targeting autoimmune and neurological disorders after three patients died.
articleDetails.fontSize.sizeحجم النص
تنويه: هذا ملخص تم إنشاؤه بواسطة الذكاء الاصطناعي
comments.heading